Cofidis Participations S.A.:企業の戦略・SWOT・財務分析

◆英語タイトル:Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3125
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Cofidis Participations S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Cofidis Participations S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Cofidis Participations S.A. (COFIDIS), a subsidiary ofthe Credit Mutuel Group, is a provider of financial and banking services along with its subsidiaries. It offers consumer finance with focus on distance lending, payment solutions, insurance solutions, loan refinancing, and banking services (current accounts, savings, online share trading and investments). It offers its services through subsidiaries and various distribution channels including in points of sale, specialist distribution networks, on the web and door to door distribution networks in France, Spain, Belgium, Italy, the Czech Republic, Portugal, Hungary, Poland, and Slovakia. COFIDIS is headquartered in Villeneuve d’Ascq, France.

Scope

- Detailed information on Cofidis Participations S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Cofidis Participations S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Cofidis Participations S.A. including a breakdown and examination of key business segments
- Intelligence on Cofidis Participations S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Cofidis Participations S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Cofidis Participations S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Cofidis Participations S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Cofidis Participations S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Cofidis Participations S.A.: Company Overview
Cofidis Participations S.A.: Overview and Key Facts
Cofidis Participations S.A.: Overview
Cofidis Participations S.A.: Key Facts
Cofidis Participations S.A.: Key Employees
Cofidis Participations S.A.: Key Employee Biographies
Cofidis Participations S.A.: Major Products and Services
Cofidis Participations S.A.: Company History
Cofidis Participations S.A.: Management Statement
Cofidis Participations S.A.: Locations and Subsidiaries
Cofidis Participations S.A.: Key Competitors
Cofidis Participations S.A.: Company Analysis
Cofidis Participations S.A.: Business Description
Cofidis Participations S.A.: SWOT Analysis
Cofidis Participations S.A.: SWOT Overview
Cofidis Participations S.A.: Strengths
Cofidis Participations S.A.: Weaknesses
Cofidis Participations S.A.: Opportunities
Cofidis Participations S.A.: Threats
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Cofidis Participations S.A.: Key Facts
Table 2: Cofidis Participations S.A.: Key Employees
Table 3: Cofidis Participations S.A.: Company History
Table 4: Cofidis Participations S.A.: Locations and Subsidiaries
Table 5: Cofidis Participations S.A.: Key Competitors

★海外企業調査レポート[Cofidis Participations S.A.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TerraForm Power Inc (TERP):電力:M&Aディール及び事業提携情報
    Summary TerraForm Power Inc (TerraForm Power), formerly SunEdison Yieldco Inc, a subsidiary of Brookfield Asset Management Inc, is an energy development company that owns and operates energy power plants. The company generates and distributes renewable energy by utilizing various clean power generat …
  • Bio-Modeling Systems SAS-製薬・医療分野:企業M&A・提携分析
    Summary Bio-Modeling Systems SAS (BM Systems) is a mechanism based medicine company which discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as Computer-Assisted Deductive Integration (CADI), which i …
  • Genocea Biosciences Inc (GNCA):企業の財務・戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea Inc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tec …
  • EnCana Corp (ECA):企業の財務・戦略的SWOT分析
    EnCana Corp (ECA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Medivir AB (MVIR B):企業の財務・戦略的SWOT分析
    Summary Medivir AB (Medivir) is a pharmaceutical company. It is engaged in drug discovery and development of treatments for cancer.The company offers products under development for the treatment of cutaneous T-cell lymphoma, osteoarthritis, solid tumors, hepatocellular carcinoma and acute myeloid le …
  • NovaDigm Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, ALS3 vaccines, vaccine clinical supplies, bacterial and fungal vaccine antigens, vaginal …
  • Royale Energy Inc (ROYL):石油・ガス:M&Aディール及び事業提携情報
    Summary Royale Energy Inc (Royale Energy) is an independent exploration and production company. The company undertakes the business of acquisition, development, and marketing of oil and natural gas properties. Its business activities comprise acquisition of oil and gas interests and proved reserves, …
  • Veritas (India) Ltd:企業の戦略・SWOT・財務情報
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Elcelyx Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Elcelyx Therapeutics Inc (Elcelyx) is a developer of novel therapies for the treatment of type 2 diabetes, kidney disease and limb amputation. The company develops drugs that regulate the gut neuroendocrine system including the L-cell, which assists in the release of glucoregulatory hormones …
  • KornFerry International (KFY):企業の財務・戦略的SWOT分析
    KornFerry International (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Old Dominion Freight Line, Inc. (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line, Inc. (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Duopharma Biotech Berhad (DPHARMA):企業の財務・戦略的SWOT分析
    Summary Duopharma Biotech Berhad (Duopharma), formerly CCM Duopharma Biotech Berhad, focuses on research, development and commercialization of generic drugs and biosimilars. The company manufactures and distributes pharmaceutical products to treat oncology and diabetes; musculo-skeletal, alimentary …
  • Sigma Pharmaceuticals Limited:戦略・SWOT・企業財務分析
    Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report Summary Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Neuravi Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Neuravi Ltd (Neuravi) is a medical device company that develops and commercializes endovascular devices and stroke treatment. The company provides embotrap revascularization device which is a thrombectomy system designed with clot-device mechanics to address challenging occlusions. Its embot …
  • Immatics Biotechnologies GmbH:企業の戦略的SWOT分析
    Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Nestle Australia Ltd:企業の戦略・SWOT・財務情報
    Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Malayan Banking Berhad:企業のM&A・事業提携・投資動向
    Malayan Banking Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Malayan Banking Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Sunshine Biopharma Inc (SBFM):製薬・医療:M&Aディール及び事業提携情報
    Summary Sunshine BioPharma Inc (Sunshine BioPharma), a subsidiary of Advanomics Corp is a pharmaceutical company that offers research, development and commercialization of drugs for treating cancer disease. The company provides generic and proprietary drugs for the treatment of cancer and other acut …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆